The Claim
Preservation of the active heterodimer sGCα1β1 in arterial smooth muscle cells inhibits tumor arteriogenesis in oropharyngeal squamous cell carcinoma.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Maintaining the sGCα1β1 protein complex in artery muscle cells reduces the formation of new blood vessels that feed oropharyngeal squamous cell tumors.
See the scientific wording
Preserving the active heterodimer sGCα1β1 in arterial smooth muscle cells may represent a potential therapeutic strategy to inhibit tumor arteriogenesis in oropharyngeal squamous cell carcinoma.
High levels of reactive molecules in the tumor environment damage a key protein complex in artery walls that normally keeps cell growth in check. When this complex breaks down, the artery cells start multiplying uncontrollably and form new arteries that feed the tumor.
What the research says
1 studyThe study found that a specific protein complex (sGCα1β1) that helps keep blood vessels relaxed and controlled breaks down near these tumors. When it breaks down, blood vessels grow uncontrollably to feed the cancer. So, keeping this protein intact might stop the cancer from building more blood vessels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.